These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 8754493

  • 41. New agents for the treatment of multiple myeloma and non-Hodgkin lymphoma.
    Oken MM.
    Cancer; 1992 Aug 15; 70(4 Suppl):946-8. PubMed ID: 1638466
    [Abstract] [Full Text] [Related]

  • 42. High-dose methylprednisolone can induce remissions in patients with fludarabine-refractory chronic lymphocytic leukaemia.
    Xu W, Miao KR, Hong M, Zhu DX, Fang C, Dong HJ, Wang DM, Cao X, Li JY.
    Eur J Cancer; 2010 Aug 15; 46(12):2145-9. PubMed ID: 20627536
    [Abstract] [Full Text] [Related]

  • 43. Efficacy of oral fludarabine in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Zhu Y, Qin Q, Xie Z.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Mar 15; 38(3):221-4. PubMed ID: 23545817
    [Abstract] [Full Text] [Related]

  • 44. Combination of GM-CSF With Fludarabine-Containing Regimens in Chronic Lymphocytic Leukemia and Indolent Non-Hodgkin Lymphoma.
    Cohen JB, Bucur S, Winton EF, Sinha R, Heffner LT, King N, Lonial S, Langston AA, Waller EK, Hutchison-Rzepka A, Colbert A, Lechowicz MJ, Flowers CR.
    Clin Lymphoma Myeloma Leuk; 2015 Sep 15; 15(9):514-8. PubMed ID: 26297176
    [Abstract] [Full Text] [Related]

  • 45. A phase II study of DT fusion protein denileukin diftitox in patients with fludarabine-refractory chronic lymphocytic leukemia.
    Frankel AE, Fleming DR, Hall PD, Powell BL, Black JH, Leftwich C, Gartenhaus R.
    Clin Cancer Res; 2003 Sep 01; 9(10 Pt 1):3555-61. PubMed ID: 14506141
    [Abstract] [Full Text] [Related]

  • 46. Present status of purine analogs in the therapy of chronic lymphocytic leukemias.
    Bergmann L.
    Leukemia; 1997 Apr 01; 11 Suppl 2():S29-34. PubMed ID: 9178835
    [Abstract] [Full Text] [Related]

  • 47. Immunosuppressive effects and clinical response of fludarabine in refractory chronic lymphocytic leukemia.
    Bergmann L, Fenchel K, Jahn B, Mitrou PS, Hoelzer D.
    Ann Oncol; 1993 May 01; 4(5):371-5. PubMed ID: 8353071
    [Abstract] [Full Text] [Related]

  • 48. Fludarabine in lymphoproliferative disorders: the Royal Marsden Hospital experience.
    O'Brien ME, Matutes E, Cunningham D, Hill M, Emmett E, Ellis PA, Milan S, Hickish T, Mercieca J, Catovsky D.
    Leuk Lymphoma; 1994 May 01; 14 Suppl 2():17-23. PubMed ID: 7881347
    [Abstract] [Full Text] [Related]

  • 49. A 3-day schedule of fludarabine in previously treated chronic lymphocytic leukemia.
    Robertson LE, O'Brien S, Kantarjian H, Koller C, Beran M, Andreeff M, Lerner S, Plunkett W, Keating MJ.
    Leukemia; 1995 Sep 01; 9(9):1444-9. PubMed ID: 7658710
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Fludarabine and cyclophosphamide with filgrastim support in patients with previously untreated indolent lymphoid malignancies.
    Flinn IW, Byrd JC, Morrison C, Jamison J, Diehl LF, Murphy T, Piantadosi S, Seifter E, Ambinder RF, Vogelsang G, Grever MR.
    Blood; 2000 Jul 01; 96(1):71-5. PubMed ID: 10891432
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Results of a fludarabine induction and alpha-interferon maintenance protocol in pretreated patients with chronic lymphocytic leukemia and low-grade non-Hodgkin's lymphoma.
    Zinzani PL, Bendandi M, Magagnoli M, Rondelli D, de Vivo A, Benni M, Zamagni E, Cavo M, Tura S.
    Eur J Haematol; 1997 Aug 01; 59(2):82-8. PubMed ID: 9293855
    [Abstract] [Full Text] [Related]

  • 58. New prospects in the treatment of indolent lymphomas with purine analogues.
    Cheson BD.
    Cancer J Sci Am; 1998 Jul 01; 4 Suppl 2():S27-36. PubMed ID: 9672772
    [Abstract] [Full Text] [Related]

  • 59. Combined fludarabine and rituximab for low grade lymphoma and chronic lymphocytic leukemia.
    Savage DG, Cohen NS, Hesdorffer CS, Heitjan D, Oster MW, Garrett TJ, Bar M, del Prete S, March R, Lonberg M, Talbot S, Mears JG, Flamm M, Taub RN, Nichols G.
    Leuk Lymphoma; 2003 Mar 01; 44(3):477-81. PubMed ID: 12688318
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.